{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Read data and create single dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import gc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def get_dataset(filename, partition):\n",
    "    file = open(filename, 'r')\n",
    "    dataset = list()\n",
    "    for line in file:\n",
    "        if line.find(\"###\") == 0:\n",
    "            abstract_id = line[4:-1]\n",
    "            seq = 0\n",
    "        elif line.strip():\n",
    "            tab_loc = line.find(\"\\t\")\n",
    "            label = line[:tab_loc]\n",
    "            text  = line[tab_loc+1:-1]\n",
    "            dataset.append([partition, abstract_id, seq, text, label])\n",
    "            seq += 1\n",
    "        else:\n",
    "            # finished reading abstract\n",
    "            pass\n",
    "    return pd.DataFrame(np.array(dataset), columns=['partition', 'abstract_id', 'seq', 'text', 'label'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 5.34 s, sys: 5.11 s, total: 10.5 s\n",
      "Wall time: 11.4 s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "\n",
    "df_train = get_dataset('input/train.txt', 'train')\n",
    "df_dev = get_dataset('input/dev.txt', 'dev')\n",
    "df_test = get_dataset('input/test.txt', 'test')\n",
    "df = pd.concat((df_train, df_dev, df_test), axis=0)\n",
    "\n",
    "del df_train, df_dev, df_test\n",
    "gc.collect()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df.to_csv('input/PubMed_20k_RCT.csv', index=None)\n",
    "df = pd.read_csv('input/PubMed_20k_RCT.csv')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Make sure database stats reflect expectations"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Partition: train\n",
      "\tNumber of abstract: 15000\n",
      "\tNumber of sentences: 180040\n",
      "Partition: dev\n",
      "\tNumber of abstract: 2500\n",
      "\tNumber of sentences: 30212\n",
      "Partition: test\n",
      "\tNumber of abstract: 2500\n",
      "\tNumber of sentences: 30135\n"
     ]
    }
   ],
   "source": [
    "def print_stats(df, partition):\n",
    "    dataset = df[df['partition']==partition]\n",
    "    print('Partition: {}'.format(partition))\n",
    "    abs_count = len(set(df[df['partition']==partition].abstract_id.values))\n",
    "    print('\\tNumber of abstract: {}'.format(abs_count))\n",
    "    print('\\tNumber of sentences: {}'.format(dataset.abstract_id.count()))\n",
    "    \n",
    "    \n",
    "print_stats(df, 'train')\n",
    "print_stats(df, 'dev')\n",
    "print_stats(df, 'test')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>partition</th>\n",
       "      <th>abstract_id</th>\n",
       "      <th>seq</th>\n",
       "      <th>text</th>\n",
       "      <th>label</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>0</td>\n",
       "      <td>To investigate the efficacy of 6 weeks of daily low-dose oral prednisolone in improving pain , mobility , and systemic low-grade inflammation in the short term and whether the effect would be sustained at 12 weeks in older adults with moderate to severe knee osteoarthritis ( OA ) .</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>1</td>\n",
       "      <td>A total of 125 patients with primary knee OA were randomized 1:1 ; 63 received 7.5 mg/day of prednisolone and 62 received placebo for 6 weeks .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>2</td>\n",
       "      <td>Outcome measures included pain reduction and improvement in function scores and systemic inflammation markers .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>3</td>\n",
       "      <td>Pain was assessed using the visual analog pain scale ( 0-100 mm ) .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>4</td>\n",
       "      <td>Secondary outcome measures included the Western Ontario and McMaster Universities Osteoarthritis Index scores , patient global assessment ( PGA ) of the severity of knee OA , and 6-min walk distance ( 6MWD ) .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>5</td>\n",
       "      <td>Serum levels of interleukin 1 ( IL-1 ) , IL-6 , tumor necrosis factor ( TNF ) - , and high-sensitivity C-reactive protein ( hsCRP ) were measured .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>6</td>\n",
       "      <td>There was a clinically relevant reduction in the intervention group compared to the placebo group for knee pain , physical function , PGA , and 6MWD at 6 weeks .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>7</td>\n",
       "      <td>The mean difference between treatment arms ( 95 % CI ) was 10.9 ( 4.8-18 .0 ) , p &lt; 0.001 ; 9.5 ( 3.7-15 .4 ) , p &lt; 0.05 ; 15.7 ( 5.3-26 .1 ) , p &lt; 0.001 ; and 86.9 ( 29.8-144 .1 ) , p &lt; 0.05 , respectively .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>8</td>\n",
       "      <td>Further , there was a clinically relevant reduction in the serum levels of IL-1 , IL-6 , TNF - , and hsCRP at 6 weeks in the intervention group when compared to the placebo group .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>9</td>\n",
       "      <td>These differences remained significant at 12 weeks .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>10</td>\n",
       "      <td>The Outcome Measures in Rheumatology Clinical Trials-Osteoarthritis Research Society International responder rate was 65 % in the intervention group and 34 % in the placebo group ( p &lt; 0.05 ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>train</td>\n",
       "      <td>4293578</td>\n",
       "      <td>11</td>\n",
       "      <td>Low-dose oral prednisolone had both a short-term and a longer sustained effect resulting in less knee pain , better physical function , and attenuation of systemic inflammation in older patients with knee OA ( ClinicalTrials.gov identifier NCT01619163 ) .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>train</td>\n",
       "      <td>4854809</td>\n",
       "      <td>0</td>\n",
       "      <td>Emotional eating is associated with overeating and the development of obesity .</td>\n",
       "      <td>BACKGROUND</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>train</td>\n",
       "      <td>4854809</td>\n",
       "      <td>1</td>\n",
       "      <td>Yet , empirical evidence for individual ( trait ) differences in emotional eating and cognitive mechanisms that contribute to eating during sad mood remain equivocal .</td>\n",
       "      <td>BACKGROUND</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>train</td>\n",
       "      <td>4854809</td>\n",
       "      <td>2</td>\n",
       "      <td>The aim of this study was to test if attention bias for food moderates the effect of self-reported emotional eating during sad mood ( vs neutral mood ) on actual food intake .</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>train</td>\n",
       "      <td>4854809</td>\n",
       "      <td>3</td>\n",
       "      <td>It was expected that emotional eating is predictive of elevated attention for food and higher food intake after an experimentally induced sad mood and that attentional maintenance on food predicts food intake during a sad versus a neutral mood .</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>train</td>\n",
       "      <td>4854809</td>\n",
       "      <td>4</td>\n",
       "      <td>Participants ( N = 85 ) were randomly assigned to one of the two experimental mood induction conditions ( sad/neutral ) .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>train</td>\n",
       "      <td>4854809</td>\n",
       "      <td>5</td>\n",
       "      <td>Attentional biases for high caloric foods were measured by eye tracking during a visual probe task with pictorial food and neutral stimuli .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>train</td>\n",
       "      <td>4854809</td>\n",
       "      <td>6</td>\n",
       "      <td>Self-reported emotional eating was assessed with the Dutch Eating Behavior Questionnaire ( DEBQ ) and ad libitum food intake was tested by a disguised food offer .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>train</td>\n",
       "      <td>4854809</td>\n",
       "      <td>7</td>\n",
       "      <td>Hierarchical multivariate regression modeling showed that self-reported emotional eating did not account for changes in attention allocation for food or food intake in either condition .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>train</td>\n",
       "      <td>4854809</td>\n",
       "      <td>8</td>\n",
       "      <td>Yet , attention maintenance on food cues was significantly related to increased intake specifically in the neutral condition , but not in the sad mood condition .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>train</td>\n",
       "      <td>4854809</td>\n",
       "      <td>9</td>\n",
       "      <td>The current findings show that self-reported emotional eating ( based on the DEBQ ) might not validly predict who overeats when sad , at least not in a laboratory setting with healthy women .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>train</td>\n",
       "      <td>4854809</td>\n",
       "      <td>10</td>\n",
       "      <td>Results further suggest that attention maintenance on food relates to eating motivation when in a neutral affective state , and might therefore be a cognitive mechanism contributing to increased food intake in general , but maybe not during sad mood .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>0</td>\n",
       "      <td>Although working smoke alarms halve deaths in residential fires , many households do not keep alarms operational .</td>\n",
       "      <td>BACKGROUND</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>1</td>\n",
       "      <td>We tested whether theory-based education increases alarm operability .</td>\n",
       "      <td>BACKGROUND</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>2</td>\n",
       "      <td>Randomised multiarm trial , with a single arm randomly selected for use each day , in low-income neighbourhoods in Maryland , USA .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>3</td>\n",
       "      <td>Intervention arms : ( 1 ) Full Education combining a health belief module with a social-cognitive theory module that provided hands-on practice installing alarm batteries and using the alarm 's hush button ; ( 2 ) Hands-on Practice social-cognitive module supplemented by typical fire department education ; ( 3 ) Current Norm receiving typical fire department education only .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>4</td>\n",
       "      <td>Four hundred and thirty-six homes recruited through churches or by knocking on doors in 2005-2008 .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>5</td>\n",
       "      <td>Follow-up visits checked alarm operability in 370 homes ( 85 % ) 1-3 .5 years after installation .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>6</td>\n",
       "      <td>number of homes with working alarms defined as alarms with working batteries or hard-wired and number of working alarms per home .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>7</td>\n",
       "      <td>Regressions controlled for alarm status preintervention ; demographics and beliefs about fire risks and alarm effectiveness .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>8</td>\n",
       "      <td>Homes in the Full Education and Practice arms were more likely to have a functioning smoke alarm at follow-up ( OR = 2.77 , 95 % CI 1.09 to 7.03 ) and had an average of 0.32 more working alarms per home ( 95 % CI 0.09 to 0.56 ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>9</td>\n",
       "      <td>Working alarms per home rose 16 % .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>10</td>\n",
       "      <td>Full Education and Practice had similar effectiveness ( p = 0.97 on both outcome measures ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>11</td>\n",
       "      <td>Without exceeding typical fire department installation time , installers can achieve greater smoke alarm operability .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>12</td>\n",
       "      <td>Hands-on practice is key .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>13</td>\n",
       "      <td>Two years after installation , for every three homes that received hands-on practice , one had an additional working alarm .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>train</td>\n",
       "      <td>5165090</td>\n",
       "      <td>14</td>\n",
       "      <td>http://www.clinicaltrials.gov number NCT00139126 .</td>\n",
       "      <td>BACKGROUND</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>0</td>\n",
       "      <td>To evaluate the performance ( efficacy , safety and acceptability ) of a new micro-adherent absorbent dressing ( UrgoClean ) compared with a hydrofiber dressing ( Aquacel ) in the local management of venous leg ulcers , in the debridement stage .</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>1</td>\n",
       "      <td>A non-inferiority European randomised controlled clinical trial ( RCT ) was conducted in 37 centres , on patients presenting with venous or predominantly venous , mixed aetiology leg ulcers at their sloughy stage ( with more than 70 % of the wound bed covered with slough at baseline ) .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>2</td>\n",
       "      <td>Patients were followed over a 6-week period and assessed weekly .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>3</td>\n",
       "      <td>The primary judgement criteria was the relative regression of the wound surface area after the 6-week treatment period .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>4</td>\n",
       "      <td>Secondary endpoints were the relative reduction of sloughy tissue and the percentage of patients presenting with a debrided wound .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>5</td>\n",
       "      <td>Altogether , 159 patients were randomised to either UrgoClean ( test group ; n = 83 ) or Aquacel ( control group ; n = 76 ) dressings .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>6</td>\n",
       "      <td>Regarding the wound healing process predictive factors ( wound area , duration , ABPI value , recurrence ) , at baseline , the two groups were well balanced , for both wound and patient characteristics .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>7</td>\n",
       "      <td>Compression therapy was administered to both groups and after a median 42-day treatment period , the percentage of relative reduction of the wound surface area was very similar ( -36.9 % vs -35.4 % in the UrgoClean and control groups , respectively ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>8</td>\n",
       "      <td>When considering the secondary criteria at week 6 , the relative reduction of sloughy tissue was significantly higher in the UrgoClean group than in the control group ( -65.3 % vs -42,6 % ; p = 0.013 ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>9</td>\n",
       "      <td>The percentage of debrided wounds was also significantly higher in the test group ( 52.5 % vs 35.1 % ; p = 0.033 ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>10</td>\n",
       "      <td>This ` EARTH ' RCT confirmed that the UrgoClean dressing has similar efficacy and safety compared to Aquacel .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>train</td>\n",
       "      <td>4633056</td>\n",
       "      <td>11</td>\n",
       "      <td>However , UrgoClean also showed better autolytic properties than the control group in the management of venous leg ulcers at the sloughy stage .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   partition  abstract_id  seq  \\\n",
       "0      train      4293578    0   \n",
       "1      train      4293578    1   \n",
       "2      train      4293578    2   \n",
       "3      train      4293578    3   \n",
       "4      train      4293578    4   \n",
       "5      train      4293578    5   \n",
       "6      train      4293578    6   \n",
       "7      train      4293578    7   \n",
       "8      train      4293578    8   \n",
       "9      train      4293578    9   \n",
       "10     train      4293578   10   \n",
       "11     train      4293578   11   \n",
       "12     train      4854809    0   \n",
       "13     train      4854809    1   \n",
       "14     train      4854809    2   \n",
       "15     train      4854809    3   \n",
       "16     train      4854809    4   \n",
       "17     train      4854809    5   \n",
       "18     train      4854809    6   \n",
       "19     train      4854809    7   \n",
       "20     train      4854809    8   \n",
       "21     train      4854809    9   \n",
       "22     train      4854809   10   \n",
       "23     train      5165090    0   \n",
       "24     train      5165090    1   \n",
       "25     train      5165090    2   \n",
       "26     train      5165090    3   \n",
       "27     train      5165090    4   \n",
       "28     train      5165090    5   \n",
       "29     train      5165090    6   \n",
       "30     train      5165090    7   \n",
       "31     train      5165090    8   \n",
       "32     train      5165090    9   \n",
       "33     train      5165090   10   \n",
       "34     train      5165090   11   \n",
       "35     train      5165090   12   \n",
       "36     train      5165090   13   \n",
       "37     train      5165090   14   \n",
       "38     train      4633056    0   \n",
       "39     train      4633056    1   \n",
       "40     train      4633056    2   \n",
       "41     train      4633056    3   \n",
       "42     train      4633056    4   \n",
       "43     train      4633056    5   \n",
       "44     train      4633056    6   \n",
       "45     train      4633056    7   \n",
       "46     train      4633056    8   \n",
       "47     train      4633056    9   \n",
       "48     train      4633056   10   \n",
       "49     train      4633056   11   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                         text  \\\n",
       "0                                                                                                  To investigate the efficacy of 6 weeks of daily low-dose oral prednisolone in improving pain , mobility , and systemic low-grade inflammation in the short term and whether the effect would be sustained at 12 weeks in older adults with moderate to severe knee osteoarthritis ( OA ) .   \n",
       "1                                                                                                                                                                                                                                             A total of 125 patients with primary knee OA were randomized 1:1 ; 63 received 7.5 mg/day of prednisolone and 62 received placebo for 6 weeks .   \n",
       "2                                                                                                                                                                                                                                                                             Outcome measures included pain reduction and improvement in function scores and systemic inflammation markers .   \n",
       "3                                                                                                                                                                                                                                                                                                                         Pain was assessed using the visual analog pain scale ( 0-100 mm ) .   \n",
       "4                                                                                                                                                                           Secondary outcome measures included the Western Ontario and McMaster Universities Osteoarthritis Index scores , patient global assessment ( PGA ) of the severity of knee OA , and 6-min walk distance ( 6MWD ) .   \n",
       "5                                                                                                                                                                                                                                         Serum levels of interleukin 1 ( IL-1 ) , IL-6 , tumor necrosis factor ( TNF ) - , and high-sensitivity C-reactive protein ( hsCRP ) were measured .   \n",
       "6                                                                                                                                                                                                                           There was a clinically relevant reduction in the intervention group compared to the placebo group for knee pain , physical function , PGA , and 6MWD at 6 weeks .   \n",
       "7                                                                                                                                                                            The mean difference between treatment arms ( 95 % CI ) was 10.9 ( 4.8-18 .0 ) , p < 0.001 ; 9.5 ( 3.7-15 .4 ) , p < 0.05 ; 15.7 ( 5.3-26 .1 ) , p < 0.001 ; and 86.9 ( 29.8-144 .1 ) , p < 0.05 , respectively .   \n",
       "8                                                                                                                                                                                                        Further , there was a clinically relevant reduction in the serum levels of IL-1 , IL-6 , TNF - , and hsCRP at 6 weeks in the intervention group when compared to the placebo group .   \n",
       "9                                                                                                                                                                                                                                                                                                                                        These differences remained significant at 12 weeks .   \n",
       "10                                                                                                                                                                                          The Outcome Measures in Rheumatology Clinical Trials-Osteoarthritis Research Society International responder rate was 65 % in the intervention group and 34 % in the placebo group ( p < 0.05 ) .   \n",
       "11                                                                                                                            Low-dose oral prednisolone had both a short-term and a longer sustained effect resulting in less knee pain , better physical function , and attenuation of systemic inflammation in older patients with knee OA ( ClinicalTrials.gov identifier NCT01619163 ) .   \n",
       "12                                                                                                                                                                                                                                                                                                            Emotional eating is associated with overeating and the development of obesity .   \n",
       "13                                                                                                                                                                                                                    Yet , empirical evidence for individual ( trait ) differences in emotional eating and cognitive mechanisms that contribute to eating during sad mood remain equivocal .   \n",
       "14                                                                                                                                                                                                            The aim of this study was to test if attention bias for food moderates the effect of self-reported emotional eating during sad mood ( vs neutral mood ) on actual food intake .   \n",
       "15                                                                                                                                      It was expected that emotional eating is predictive of elevated attention for food and higher food intake after an experimentally induced sad mood and that attentional maintenance on food predicts food intake during a sad versus a neutral mood .   \n",
       "16                                                                                                                                                                                                                                                                  Participants ( N = 85 ) were randomly assigned to one of the two experimental mood induction conditions ( sad/neutral ) .   \n",
       "17                                                                                                                                                                                                                                               Attentional biases for high caloric foods were measured by eye tracking during a visual probe task with pictorial food and neutral stimuli .   \n",
       "18                                                                                                                                                                                                                        Self-reported emotional eating was assessed with the Dutch Eating Behavior Questionnaire ( DEBQ ) and ad libitum food intake was tested by a disguised food offer .   \n",
       "19                                                                                                                                                                                                 Hierarchical multivariate regression modeling showed that self-reported emotional eating did not account for changes in attention allocation for food or food intake in either condition .   \n",
       "20                                                                                                                                                                                                                         Yet , attention maintenance on food cues was significantly related to increased intake specifically in the neutral condition , but not in the sad mood condition .   \n",
       "21                                                                                                                                                                                            The current findings show that self-reported emotional eating ( based on the DEBQ ) might not validly predict who overeats when sad , at least not in a laboratory setting with healthy women .   \n",
       "22                                                                                                                                Results further suggest that attention maintenance on food relates to eating motivation when in a neutral affective state , and might therefore be a cognitive mechanism contributing to increased food intake in general , but maybe not during sad mood .   \n",
       "23                                                                                                                                                                                                                                                                         Although working smoke alarms halve deaths in residential fires , many households do not keep alarms operational .   \n",
       "24                                                                                                                                                                                                                                                                                                                     We tested whether theory-based education increases alarm operability .   \n",
       "25                                                                                                                                                                                                                                                        Randomised multiarm trial , with a single arm randomly selected for use each day , in low-income neighbourhoods in Maryland , USA .   \n",
       "26  Intervention arms : ( 1 ) Full Education combining a health belief module with a social-cognitive theory module that provided hands-on practice installing alarm batteries and using the alarm 's hush button ; ( 2 ) Hands-on Practice social-cognitive module supplemented by typical fire department education ; ( 3 ) Current Norm receiving typical fire department education only .   \n",
       "27                                                                                                                                                                                                                                                                                        Four hundred and thirty-six homes recruited through churches or by knocking on doors in 2005-2008 .   \n",
       "28                                                                                                                                                                                                                                                                                         Follow-up visits checked alarm operability in 370 homes ( 85 % ) 1-3 .5 years after installation .   \n",
       "29                                                                                                                                                                                                                                                         number of homes with working alarms defined as alarms with working batteries or hard-wired and number of working alarms per home .   \n",
       "30                                                                                                                                                                                                                                                              Regressions controlled for alarm status preintervention ; demographics and beliefs about fire risks and alarm effectiveness .   \n",
       "31                                                                                                                                                      Homes in the Full Education and Practice arms were more likely to have a functioning smoke alarm at follow-up ( OR = 2.77 , 95 % CI 1.09 to 7.03 ) and had an average of 0.32 more working alarms per home ( 95 % CI 0.09 to 0.56 ) .   \n",
       "32                                                                                                                                                                                                                                                                                                                                                        Working alarms per home rose 16 % .   \n",
       "33                                                                                                                                                                                                                                                                                              Full Education and Practice had similar effectiveness ( p = 0.97 on both outcome measures ) .   \n",
       "34                                                                                                                                                                                                                                                                     Without exceeding typical fire department installation time , installers can achieve greater smoke alarm operability .   \n",
       "35                                                                                                                                                                                                                                                                                                                                                                 Hands-on practice is key .   \n",
       "36                                                                                                                                                                                                                                                               Two years after installation , for every three homes that received hands-on practice , one had an additional working alarm .   \n",
       "37                                                                                                                                                                                                                                                                                                                                         http://www.clinicaltrials.gov number NCT00139126 .   \n",
       "38                                                                                                                                     To evaluate the performance ( efficacy , safety and acceptability ) of a new micro-adherent absorbent dressing ( UrgoClean ) compared with a hydrofiber dressing ( Aquacel ) in the local management of venous leg ulcers , in the debridement stage .   \n",
       "39                                                                                            A non-inferiority European randomised controlled clinical trial ( RCT ) was conducted in 37 centres , on patients presenting with venous or predominantly venous , mixed aetiology leg ulcers at their sloughy stage ( with more than 70 % of the wound bed covered with slough at baseline ) .   \n",
       "40                                                                                                                                                                                                                                                                                                                          Patients were followed over a 6-week period and assessed weekly .   \n",
       "41                                                                                                                                                                                                                                                                   The primary judgement criteria was the relative regression of the wound surface area after the 6-week treatment period .   \n",
       "42                                                                                                                                                                                                                                                        Secondary endpoints were the relative reduction of sloughy tissue and the percentage of patients presenting with a debrided wound .   \n",
       "43                                                                                                                                                                                                                                                    Altogether , 159 patients were randomised to either UrgoClean ( test group ; n = 83 ) or Aquacel ( control group ; n = 76 ) dressings .   \n",
       "44                                                                                                                                                                                Regarding the wound healing process predictive factors ( wound area , duration , ABPI value , recurrence ) , at baseline , the two groups were well balanced , for both wound and patient characteristics .   \n",
       "45                                                                                                                               Compression therapy was administered to both groups and after a median 42-day treatment period , the percentage of relative reduction of the wound surface area was very similar ( -36.9 % vs -35.4 % in the UrgoClean and control groups , respectively ) .   \n",
       "46                                                                                                                                                                                When considering the secondary criteria at week 6 , the relative reduction of sloughy tissue was significantly higher in the UrgoClean group than in the control group ( -65.3 % vs -42,6 % ; p = 0.013 ) .   \n",
       "47                                                                                                                                                                                                                                                                       The percentage of debrided wounds was also significantly higher in the test group ( 52.5 % vs 35.1 % ; p = 0.033 ) .   \n",
       "48                                                                                                                                                                                                                                                                             This ` EARTH ' RCT confirmed that the UrgoClean dressing has similar efficacy and safety compared to Aquacel .   \n",
       "49                                                                                                                                                                                                                                           However , UrgoClean also showed better autolytic properties than the control group in the management of venous leg ulcers at the sloughy stage .   \n",
       "\n",
       "          label  \n",
       "0     OBJECTIVE  \n",
       "1       METHODS  \n",
       "2       METHODS  \n",
       "3       METHODS  \n",
       "4       METHODS  \n",
       "5       METHODS  \n",
       "6       RESULTS  \n",
       "7       RESULTS  \n",
       "8       RESULTS  \n",
       "9       RESULTS  \n",
       "10      RESULTS  \n",
       "11  CONCLUSIONS  \n",
       "12   BACKGROUND  \n",
       "13   BACKGROUND  \n",
       "14    OBJECTIVE  \n",
       "15    OBJECTIVE  \n",
       "16      METHODS  \n",
       "17      METHODS  \n",
       "18      METHODS  \n",
       "19      RESULTS  \n",
       "20      RESULTS  \n",
       "21  CONCLUSIONS  \n",
       "22  CONCLUSIONS  \n",
       "23   BACKGROUND  \n",
       "24   BACKGROUND  \n",
       "25      METHODS  \n",
       "26      METHODS  \n",
       "27      METHODS  \n",
       "28      METHODS  \n",
       "29      METHODS  \n",
       "30      METHODS  \n",
       "31      RESULTS  \n",
       "32      RESULTS  \n",
       "33      RESULTS  \n",
       "34  CONCLUSIONS  \n",
       "35  CONCLUSIONS  \n",
       "36  CONCLUSIONS  \n",
       "37   BACKGROUND  \n",
       "38    OBJECTIVE  \n",
       "39      METHODS  \n",
       "40      METHODS  \n",
       "41      METHODS  \n",
       "42      METHODS  \n",
       "43      RESULTS  \n",
       "44      RESULTS  \n",
       "45      RESULTS  \n",
       "46      RESULTS  \n",
       "47      RESULTS  \n",
       "48  CONCLUSIONS  \n",
       "49  CONCLUSIONS  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('max_colwidth',500)\n",
    "df.head(50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>partition</th>\n",
       "      <th>abstract_id</th>\n",
       "      <th>seq</th>\n",
       "      <th>text</th>\n",
       "      <th>label</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>240337</th>\n",
       "      <td>test</td>\n",
       "      <td>5195125</td>\n",
       "      <td>11</td>\n",
       "      <td>This study protocol has been listed in the Australia New Zealand Clinical Trial Registry ( registration number : ACTRN12612000340831 ) on 23 March 2012 .</td>\n",
       "      <td>BACKGROUND</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240338</th>\n",
       "      <td>test</td>\n",
       "      <td>5342855</td>\n",
       "      <td>0</td>\n",
       "      <td>The aim of the present study was to evaluate the natural course of acute incomplete stent apposition ( ISA ) after second-generation everolimus-eluting stent ( EES ) when compared with first-generation sirolimus-eluting stent ( SES ) by using optical coherence tomography ( OCT ) .</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240339</th>\n",
       "      <td>test</td>\n",
       "      <td>5342855</td>\n",
       "      <td>1</td>\n",
       "      <td>From the OCT substudy of the RESET trial , we identified 77 patients ( EES = 38 and SES = 39 ) who successfully underwent serial OCT examination at post-stenting and 8-12-month follow-up .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240340</th>\n",
       "      <td>test</td>\n",
       "      <td>5342855</td>\n",
       "      <td>2</td>\n",
       "      <td>The presence of ISA was assessed in the OCT images , and ISA distance was measured from the centre of the strut blooming to the adjacent lumen border .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240341</th>\n",
       "      <td>test</td>\n",
       "      <td>5342855</td>\n",
       "      <td>3</td>\n",
       "      <td>Incomplete stent apposition was observed in all EES and SES at post-stenting , and it was persistent in 26 % of EES and 38 % of SES at 8-12-month follow-up .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240342</th>\n",
       "      <td>test</td>\n",
       "      <td>5342855</td>\n",
       "      <td>4</td>\n",
       "      <td>Maximum ISA distance was significantly decreased during the follow-up period in both EES ( 315 94-110 165 m , P &lt; 0.001 ) and SES ( 308 119-143 195 m , P &lt; 0.001 ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240343</th>\n",
       "      <td>test</td>\n",
       "      <td>5342855</td>\n",
       "      <td>5</td>\n",
       "      <td>Receiver-operating curve analysis identified that the best cut-off value of OCT-estimated ISA distance at post-stenting for predicting late-persistent ISA at 8-12-month follow-up in EES and SES was &gt; 355 and &gt; 285 m , respectively .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240344</th>\n",
       "      <td>test</td>\n",
       "      <td>5342855</td>\n",
       "      <td>6</td>\n",
       "      <td>The second-generation EES showed better healing of acute ISA in comparison with the first-generation SES .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240345</th>\n",
       "      <td>test</td>\n",
       "      <td>5342855</td>\n",
       "      <td>7</td>\n",
       "      <td>Optical coherence tomography can predict late-persistent ISA after DES implantation and provide useful information to optimize PCI .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240346</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>0</td>\n",
       "      <td>Small single-center comparative studies suggest improved outcomes in cardiac resynchronization therapy ( CRT ) patients implanted with a quadripolar left ventricular ( LV ) lead in comparison with non-quadripolar ( bipolar ) leads .</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240347</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>1</td>\n",
       "      <td>This study represents the first large multicenter prospective registry comparing implant and 6-month postoperative lead performance following CRT-defibrillator ( CRT-D ) implantation with quadripolar vs. bipolar leads .</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240348</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>2</td>\n",
       "      <td>During a 39-month period , 418 consecutive patients having CRT-D implantation attempts with either a quadripolar ( n = 230 ) or bipolar LV lead ( n = 188 ) were enrolled in the registry .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240349</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>3</td>\n",
       "      <td>The primary outcome of the study was LV lead failure defined as any abnormality , excluding infection , resulting in surgical lead revision or CRT termination .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240350</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>4</td>\n",
       "      <td>Additionally , operative and follow-up data were analyzed for significant difference between groups .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240351</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>5</td>\n",
       "      <td>Baseline characteristics of both groups were similar .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240352</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>6</td>\n",
       "      <td>In 72.9 % of quadripolar leads versus 65.0 % of bipolar leads , the LV lead successfully engaged the predefined ideal target side branch ( p = 0.47 ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240353</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>7</td>\n",
       "      <td>Implant duration and fluoroscopy times were significantly shorter when a quadripolar lead was used ( p = 0.007 and p = 0.001 , respectively ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240354</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>8</td>\n",
       "      <td>The primary end point occurred in six patients ( 2.7 % ) in the quadripolar group and in 14 patients ( 8.0 % ) in the bipolar group ( p = 0.02 ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240355</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>9</td>\n",
       "      <td>Clinically significant phrenic nerve stimulation ( PNS ) occurred in 4.6 vs. 14.2 % of quadripolar vs. bipolar patients , respectively ( p = 0.002 ) ; all PNS were resolved noninvasively through programming in the quadripolar group vs. 84 % in bipolar group ( p = 0.75 ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240356</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>10</td>\n",
       "      <td>The use of a bipolar lead was associated with a higher risk of surgical LV lead revision ( 6.3 vs. 2.3 % ; p = 0.057 ) and a higher incidence of dislodgment ( 5.7 vs. 2.7 % ; p = 0.16 ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240357</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>11</td>\n",
       "      <td>This multicenter study demonstrates that the use of a quadripolar LV lead results in significantly lower rates of lead-related problems and reduced procedural and fluoroscopic times for biventricular system implantation .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240358</th>\n",
       "      <td>test</td>\n",
       "      <td>5504267</td>\n",
       "      <td>12</td>\n",
       "      <td>This has important implications for LV pacing lead choice .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240359</th>\n",
       "      <td>test</td>\n",
       "      <td>5028463</td>\n",
       "      <td>0</td>\n",
       "      <td>Rapid sputum culture conversion at 2 months indicates the sterilizing capacity and potential of regimens to shorten duration of tuberculosis treatment .</td>\n",
       "      <td>BACKGROUND</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240360</th>\n",
       "      <td>test</td>\n",
       "      <td>5028463</td>\n",
       "      <td>1</td>\n",
       "      <td>We compared results of sputum culture conversion by moxifloxacin and control regimens and identified factors affecting sputum culture positivity after 2 months of treatment .</td>\n",
       "      <td>BACKGROUND</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240361</th>\n",
       "      <td>test</td>\n",
       "      <td>5028463</td>\n",
       "      <td>2</td>\n",
       "      <td>Human immunodeficiency virus-uninfected adults with newly diagnosed smear-positive pulmonary tuberculosis were randomized to receive a 3 - or 4-month moxifloxacin regimen ( moxifloxacin [ M ] , isoniazid [ H ] , rifampicin [ R ] , pyrazinamide [ Z ] , ethambutol [ E ] ) or the control regimen ( RHZE thrice weekly ) .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240362</th>\n",
       "      <td>test</td>\n",
       "      <td>5028463</td>\n",
       "      <td>3</td>\n",
       "      <td>Bacteriological assessments were done at 15 , 30 , 45 , and 60 days of treatment .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240363</th>\n",
       "      <td>test</td>\n",
       "      <td>5028463</td>\n",
       "      <td>4</td>\n",
       "      <td>Because all patients in the moxifloxacin groups received 2 months of daily RHZEM , they were grouped together for analysis .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240364</th>\n",
       "      <td>test</td>\n",
       "      <td>5028463</td>\n",
       "      <td>5</td>\n",
       "      <td>Statistical methods included ( 2 ) test and logistic regression analysis .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240365</th>\n",
       "      <td>test</td>\n",
       "      <td>5028463</td>\n",
       "      <td>6</td>\n",
       "      <td>Sputum culture conversion was analyzed in 780 ( 616 in the moxifloxacin group and 164 in the control group ) of 801 enrolled patients .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240366</th>\n",
       "      <td>test</td>\n",
       "      <td>5028463</td>\n",
       "      <td>7</td>\n",
       "      <td>Ninety-five percent of 590 patients in the moxifloxacin group and 81 % of 151 patients in the control group had negative sputum cultures at month 2 ( P &lt; .001 ) .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240367</th>\n",
       "      <td>test</td>\n",
       "      <td>5028463</td>\n",
       "      <td>8</td>\n",
       "      <td>The control regimen , age ( 35 years ) , initial sputum culture grade ( 2 + or 3 + ) , and male sex were significantly associated with higher odds of positive sputum cultures at 2 months .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240368</th>\n",
       "      <td>test</td>\n",
       "      <td>5028463</td>\n",
       "      <td>9</td>\n",
       "      <td>A 5-drug daily regimen with moxifloxacin results in significantly higher sputum culture conversion in the first 2 months compared with a thrice-weekly , 4-drug regimen in patients with newly diagnosed sputum-positive pulmonary tuberculosis .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240369</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized clinical trial .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240370</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>1</td>\n",
       "      <td>To compare the effectiveness of the Alfredson eccentric heel-drop protocol with a `` do-as-tolerated '' protocol for nonathletic individuals with midportion Achilles tendinopathy .</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240371</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>2</td>\n",
       "      <td>The Alfredson protocol recommends the completion of 180 eccentric heel drops a day .</td>\n",
       "      <td>BACKGROUND</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240372</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>3</td>\n",
       "      <td>However , completing this large number of repetitions is time consuming and potentially uncomfortable .</td>\n",
       "      <td>BACKGROUND</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240373</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>4</td>\n",
       "      <td>There is a need to investigate varying exercise dosages that minimize the discomfort yet retain the clinical benefits .</td>\n",
       "      <td>BACKGROUND</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240374</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>5</td>\n",
       "      <td>Twenty-eight individuals from outpatient physiotherapy departments were randomized to either the standard ( n = 15 ) or the do-as-tolerated ( n = 13 ) 6-week intervention protocol .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240375</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>6</td>\n",
       "      <td>Apart from repetition volume , all other aspects of management were standardized between groups .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240376</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>7</td>\n",
       "      <td>Tendinopathy clinical severity was assessed with the Victorian Institute of Sport Assessment-Achilles ( VISA-A ) questionnaire .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240377</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>8</td>\n",
       "      <td>Pain intensity was assessed using a visual analog scale ( VAS ) .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240378</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>9</td>\n",
       "      <td>Both were assessed at baseline , 3 weeks , and 6 weeks .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240379</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>10</td>\n",
       "      <td>Treatment satisfaction was assessed at week 6 .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240380</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>11</td>\n",
       "      <td>Adverse effects were also monitored .</td>\n",
       "      <td>METHODS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240381</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>12</td>\n",
       "      <td>There was a statistically significant within-group improvement in VISA-A score for both groups ( standard , P = .03 ; do as tolerated , P &lt; .001 ) and VAS pain for the do-as-tolerated group ( P = .001 ) at week 6 , based on the intention-to-treat analysis .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240382</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>13</td>\n",
       "      <td>There was a statistically significant between-group difference in VISA-A scores at week 3 , based on both the intention-to-treat ( P = .004 ) and per-protocol analyses ( P = .007 ) , partly due to a within-group deterioration at week 3 in the standard group .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240383</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>14</td>\n",
       "      <td>There were no statistically significant between-group differences for VISA-A and VAS pain scores at week 6 , the completion of the intervention .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240384</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>15</td>\n",
       "      <td>There was no significant association between satisfaction and treatment groups at week 6 .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240385</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>16</td>\n",
       "      <td>No adverse effects were reported .</td>\n",
       "      <td>RESULTS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240386</th>\n",
       "      <td>test</td>\n",
       "      <td>4261927</td>\n",
       "      <td>17</td>\n",
       "      <td>Performing a 6-week do-as-tolerated program of eccentric heel-drop exercises , compared to the recommended 180 repetitions per day , did not lead to lesser improvement for individuals with midportion Achilles tendinopathy , based on VISA-A and VAS scores .</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       partition  abstract_id  seq  \\\n",
       "240337      test      5195125   11   \n",
       "240338      test      5342855    0   \n",
       "240339      test      5342855    1   \n",
       "240340      test      5342855    2   \n",
       "240341      test      5342855    3   \n",
       "240342      test      5342855    4   \n",
       "240343      test      5342855    5   \n",
       "240344      test      5342855    6   \n",
       "240345      test      5342855    7   \n",
       "240346      test      5504267    0   \n",
       "240347      test      5504267    1   \n",
       "240348      test      5504267    2   \n",
       "240349      test      5504267    3   \n",
       "240350      test      5504267    4   \n",
       "240351      test      5504267    5   \n",
       "240352      test      5504267    6   \n",
       "240353      test      5504267    7   \n",
       "240354      test      5504267    8   \n",
       "240355      test      5504267    9   \n",
       "240356      test      5504267   10   \n",
       "240357      test      5504267   11   \n",
       "240358      test      5504267   12   \n",
       "240359      test      5028463    0   \n",
       "240360      test      5028463    1   \n",
       "240361      test      5028463    2   \n",
       "240362      test      5028463    3   \n",
       "240363      test      5028463    4   \n",
       "240364      test      5028463    5   \n",
       "240365      test      5028463    6   \n",
       "240366      test      5028463    7   \n",
       "240367      test      5028463    8   \n",
       "240368      test      5028463    9   \n",
       "240369      test      4261927    0   \n",
       "240370      test      4261927    1   \n",
       "240371      test      4261927    2   \n",
       "240372      test      4261927    3   \n",
       "240373      test      4261927    4   \n",
       "240374      test      4261927    5   \n",
       "240375      test      4261927    6   \n",
       "240376      test      4261927    7   \n",
       "240377      test      4261927    8   \n",
       "240378      test      4261927    9   \n",
       "240379      test      4261927   10   \n",
       "240380      test      4261927   11   \n",
       "240381      test      4261927   12   \n",
       "240382      test      4261927   13   \n",
       "240383      test      4261927   14   \n",
       "240384      test      4261927   15   \n",
       "240385      test      4261927   16   \n",
       "240386      test      4261927   17   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                  text  \\\n",
       "240337                                                                                                                                                                       This study protocol has been listed in the Australia New Zealand Clinical Trial Registry ( registration number : ACTRN12612000340831 ) on 23 March 2012 .   \n",
       "240338                                       The aim of the present study was to evaluate the natural course of acute incomplete stent apposition ( ISA ) after second-generation everolimus-eluting stent ( EES ) when compared with first-generation sirolimus-eluting stent ( SES ) by using optical coherence tomography ( OCT ) .   \n",
       "240339                                                                                                                                    From the OCT substudy of the RESET trial , we identified 77 patients ( EES = 38 and SES = 39 ) who successfully underwent serial OCT examination at post-stenting and 8-12-month follow-up .   \n",
       "240340                                                                                                                                                                         The presence of ISA was assessed in the OCT images , and ISA distance was measured from the centre of the strut blooming to the adjacent lumen border .   \n",
       "240341                                                                                                                                                                   Incomplete stent apposition was observed in all EES and SES at post-stenting , and it was persistent in 26 % of EES and 38 % of SES at 8-12-month follow-up .   \n",
       "240342                                                                                                                                                           Maximum ISA distance was significantly decreased during the follow-up period in both EES ( 315 94-110 165 m , P < 0.001 ) and SES ( 308 119-143 195 m , P < 0.001 ) .   \n",
       "240343                                                                                        Receiver-operating curve analysis identified that the best cut-off value of OCT-estimated ISA distance at post-stenting for predicting late-persistent ISA at 8-12-month follow-up in EES and SES was > 355 and > 285 m , respectively .   \n",
       "240344                                                                                                                                                                                                                      The second-generation EES showed better healing of acute ISA in comparison with the first-generation SES .   \n",
       "240345                                                                                                                                                                                            Optical coherence tomography can predict late-persistent ISA after DES implantation and provide useful information to optimize PCI .   \n",
       "240346                                                                                        Small single-center comparative studies suggest improved outcomes in cardiac resynchronization therapy ( CRT ) patients implanted with a quadripolar left ventricular ( LV ) lead in comparison with non-quadripolar ( bipolar ) leads .   \n",
       "240347                                                                                                     This study represents the first large multicenter prospective registry comparing implant and 6-month postoperative lead performance following CRT-defibrillator ( CRT-D ) implantation with quadripolar vs. bipolar leads .   \n",
       "240348                                                                                                                                     During a 39-month period , 418 consecutive patients having CRT-D implantation attempts with either a quadripolar ( n = 230 ) or bipolar LV lead ( n = 188 ) were enrolled in the registry .   \n",
       "240349                                                                                                                                                                The primary outcome of the study was LV lead failure defined as any abnormality , excluding infection , resulting in surgical lead revision or CRT termination .   \n",
       "240350                                                                                                                                                                                                                           Additionally , operative and follow-up data were analyzed for significant difference between groups .   \n",
       "240351                                                                                                                                                                                                                                                                          Baseline characteristics of both groups were similar .   \n",
       "240352                                                                                                                                                                         In 72.9 % of quadripolar leads versus 65.0 % of bipolar leads , the LV lead successfully engaged the predefined ideal target side branch ( p = 0.47 ) .   \n",
       "240353                                                                                                                                                                                 Implant duration and fluoroscopy times were significantly shorter when a quadripolar lead was used ( p = 0.007 and p = 0.001 , respectively ) .   \n",
       "240354                                                                                                                                                                              The primary end point occurred in six patients ( 2.7 % ) in the quadripolar group and in 14 patients ( 8.0 % ) in the bipolar group ( p = 0.02 ) .   \n",
       "240355                                                Clinically significant phrenic nerve stimulation ( PNS ) occurred in 4.6 vs. 14.2 % of quadripolar vs. bipolar patients , respectively ( p = 0.002 ) ; all PNS were resolved noninvasively through programming in the quadripolar group vs. 84 % in bipolar group ( p = 0.75 ) .   \n",
       "240356                                                                                                                                     The use of a bipolar lead was associated with a higher risk of surgical LV lead revision ( 6.3 vs. 2.3 % ; p = 0.057 ) and a higher incidence of dislodgment ( 5.7 vs. 2.7 % ; p = 0.16 ) .   \n",
       "240357                                                                                                   This multicenter study demonstrates that the use of a quadripolar LV lead results in significantly lower rates of lead-related problems and reduced procedural and fluoroscopic times for biventricular system implantation .   \n",
       "240358                                                                                                                                                                                                                                                                     This has important implications for LV pacing lead choice .   \n",
       "240359                                                                                                                                                                        Rapid sputum culture conversion at 2 months indicates the sterilizing capacity and potential of regimens to shorten duration of tuberculosis treatment .   \n",
       "240360                                                                                                                                                  We compared results of sputum culture conversion by moxifloxacin and control regimens and identified factors affecting sputum culture positivity after 2 months of treatment .   \n",
       "240361  Human immunodeficiency virus-uninfected adults with newly diagnosed smear-positive pulmonary tuberculosis were randomized to receive a 3 - or 4-month moxifloxacin regimen ( moxifloxacin [ M ] , isoniazid [ H ] , rifampicin [ R ] , pyrazinamide [ Z ] , ethambutol [ E ] ) or the control regimen ( RHZE thrice weekly ) .   \n",
       "240362                                                                                                                                                                                                                                              Bacteriological assessments were done at 15 , 30 , 45 , and 60 days of treatment .   \n",
       "240363                                                                                                                                                                                                    Because all patients in the moxifloxacin groups received 2 months of daily RHZEM , they were grouped together for analysis .   \n",
       "240364                                                                                                                                                                                                                                                      Statistical methods included ( 2 ) test and logistic regression analysis .   \n",
       "240365                                                                                                                                                                                         Sputum culture conversion was analyzed in 780 ( 616 in the moxifloxacin group and 164 in the control group ) of 801 enrolled patients .   \n",
       "240366                                                                                                                                                              Ninety-five percent of 590 patients in the moxifloxacin group and 81 % of 151 patients in the control group had negative sputum cultures at month 2 ( P < .001 ) .   \n",
       "240367                                                                                                                                    The control regimen , age ( 35 years ) , initial sputum culture grade ( 2 + or 3 + ) , and male sex were significantly associated with higher odds of positive sputum cultures at 2 months .   \n",
       "240368                                                                               A 5-drug daily regimen with moxifloxacin results in significantly higher sputum culture conversion in the first 2 months compared with a thrice-weekly , 4-drug regimen in patients with newly diagnosed sputum-positive pulmonary tuberculosis .   \n",
       "240369                                                                                                                                                                                                                                                                                                     Randomized clinical trial .   \n",
       "240370                                                                                                                                            To compare the effectiveness of the Alfredson eccentric heel-drop protocol with a `` do-as-tolerated '' protocol for nonathletic individuals with midportion Achilles tendinopathy .   \n",
       "240371                                                                                                                                                                                                                                            The Alfredson protocol recommends the completion of 180 eccentric heel drops a day .   \n",
       "240372                                                                                                                                                                                                                         However , completing this large number of repetitions is time consuming and potentially uncomfortable .   \n",
       "240373                                                                                                                                                                                                         There is a need to investigate varying exercise dosages that minimize the discomfort yet retain the clinical benefits .   \n",
       "240374                                                                                                                                           Twenty-eight individuals from outpatient physiotherapy departments were randomized to either the standard ( n = 15 ) or the do-as-tolerated ( n = 13 ) 6-week intervention protocol .   \n",
       "240375                                                                                                                                                                                                                               Apart from repetition volume , all other aspects of management were standardized between groups .   \n",
       "240376                                                                                                                                                                                                Tendinopathy clinical severity was assessed with the Victorian Institute of Sport Assessment-Achilles ( VISA-A ) questionnaire .   \n",
       "240377                                                                                                                                                                                                                                                               Pain intensity was assessed using a visual analog scale ( VAS ) .   \n",
       "240378                                                                                                                                                                                                                                                                        Both were assessed at baseline , 3 weeks , and 6 weeks .   \n",
       "240379                                                                                                                                                                                                                                                                                 Treatment satisfaction was assessed at week 6 .   \n",
       "240380                                                                                                                                                                                                                                                                                           Adverse effects were also monitored .   \n",
       "240381                                                               There was a statistically significant within-group improvement in VISA-A score for both groups ( standard , P = .03 ; do as tolerated , P < .001 ) and VAS pain for the do-as-tolerated group ( P = .001 ) at week 6 , based on the intention-to-treat analysis .   \n",
       "240382                                                             There was a statistically significant between-group difference in VISA-A scores at week 3 , based on both the intention-to-treat ( P = .004 ) and per-protocol analyses ( P = .007 ) , partly due to a within-group deterioration at week 3 in the standard group .   \n",
       "240383                                                                                                                                                                               There were no statistically significant between-group differences for VISA-A and VAS pain scores at week 6 , the completion of the intervention .   \n",
       "240384                                                                                                                                                                                                                                      There was no significant association between satisfaction and treatment groups at week 6 .   \n",
       "240385                                                                                                                                                                                                                                                                                              No adverse effects were reported .   \n",
       "240386                                                                Performing a 6-week do-as-tolerated program of eccentric heel-drop exercises , compared to the recommended 180 repetitions per day , did not lead to lesser improvement for individuals with midportion Achilles tendinopathy , based on VISA-A and VAS scores .   \n",
       "\n",
       "              label  \n",
       "240337   BACKGROUND  \n",
       "240338    OBJECTIVE  \n",
       "240339      RESULTS  \n",
       "240340      RESULTS  \n",
       "240341      RESULTS  \n",
       "240342      RESULTS  \n",
       "240343      RESULTS  \n",
       "240344  CONCLUSIONS  \n",
       "240345  CONCLUSIONS  \n",
       "240346    OBJECTIVE  \n",
       "240347    OBJECTIVE  \n",
       "240348      METHODS  \n",
       "240349      METHODS  \n",
       "240350      METHODS  \n",
       "240351      RESULTS  \n",
       "240352      RESULTS  \n",
       "240353      RESULTS  \n",
       "240354      RESULTS  \n",
       "240355      RESULTS  \n",
       "240356      RESULTS  \n",
       "240357  CONCLUSIONS  \n",
       "240358  CONCLUSIONS  \n",
       "240359   BACKGROUND  \n",
       "240360   BACKGROUND  \n",
       "240361      METHODS  \n",
       "240362      METHODS  \n",
       "240363      METHODS  \n",
       "240364      METHODS  \n",
       "240365      RESULTS  \n",
       "240366      RESULTS  \n",
       "240367      RESULTS  \n",
       "240368  CONCLUSIONS  \n",
       "240369      METHODS  \n",
       "240370    OBJECTIVE  \n",
       "240371   BACKGROUND  \n",
       "240372   BACKGROUND  \n",
       "240373   BACKGROUND  \n",
       "240374      METHODS  \n",
       "240375      METHODS  \n",
       "240376      METHODS  \n",
       "240377      METHODS  \n",
       "240378      METHODS  \n",
       "240379      METHODS  \n",
       "240380      METHODS  \n",
       "240381      RESULTS  \n",
       "240382      RESULTS  \n",
       "240383      RESULTS  \n",
       "240384      RESULTS  \n",
       "240385      RESULTS  \n",
       "240386  CONCLUSIONS  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.tail(50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.5.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
